Viewing Opinion | StockChase

Johnson & Johnson (JNJ-N) opinion on 2017-04-20

Last Price Recorded: 142.8900 on 2017-12-13

ON STOCKCHASE SINCE Oct 2000

biotechnology/pharmaceutical
biotechnology/pharmaceutical
TOP PICK

Lorne Zeiler
Johnson & Johnson was $121.870 at time of opinion
Owned : Yes

Recently missed on revenues and the stock sold off a bit. They actually beat on the earnings per share. This company has 3 solid lines of business, pharmaceuticals, consumer products and medical devices. There should be significant earnings growth this year. They did a significant acquisition last year which should be coming into earnings this year. Trading at about 20X earnings. Dividend yield of 2.6%. (Analysts’ price target is $130.)

UNKNOWN

All opinions for JNJ-N (382)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
28 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
36 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

All opinions for JNJ-N (382)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
28 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
36 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

Last 60 Days Opinions

HOLD
14 hours ago
PAST TOP PICK
2 days ago
COMMENT
1 month ago

No Comments.


You must be logged in to comment.

Successfully Saved Company